Opinion|Videos|April 1, 2025
Empowering Patients and Addressing Concerns in IUD Placement
Author(s)Lisa Bayer, MD, MPH
Panelists discuss how developing an effective pain management plan for intrauterine device (IUD) insertion requires patient cooperation, thorough medical history review, comprehensive education about procedures and tools, consideration of individualized needs, planning for interventions like sedation or antianxiety medication (which may not always be available), and implementation of trauma-informed care principles to ensure true informed consent and patient autonomy.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Developing a pain plan involves cooperation with the patient and an examination of their medical history.
- Patient education and autonomy are key to informed consent.
- Interventions like sedation, antianxiety medication, etc, require planning ahead of time and may not be available.
- Patient education strategies encompass visual diagrams of a procedure to learning about the tools that will be used.
- Find out from the patient what works best for them.
- The principles of trauma-informed care
Advertisement
Related to this article
Menopause proteomics were consistently associated with inflammatory brain aging and Alzheimer’s dementia risk across nearly 15,000 women in a new study published in Nature Medicine.
A real-world study presented at Psych Congress found that zuranolone's PPD symptom improvements were sustained through day 90.
A new Gallup survey found 51% of women in the United States reported negative healthcare experiences.
Hugh Taylor, MD, explains that imaging in endometriosis is best for ruling out other causes of pelvic pain and cannot exclude the diagnosis.
David Shalowitz, MD, MSHP, emphasizes spreading awareness of opportunistic salpingectomy across specialties while grounding its use in shared decision-making.
SMFM states abortion care is core to MFM practice and urges institutional action to protect high-risk patient access.
Hugh Taylor, MD, welcomes ACOG's new guidance allowing clinical, nonsurgical diagnosis of endometriosis and emphasizes it is a systemic disease affecting the whole body.
FDA accepted for review an sNDA for MIUDELLA copper IUD for a 6-year duration, with a PDUFA date in Q2 2027.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Zuranolone shows sustained PPD symptom improvement through day 90
2
Sameena Rahman, MD, on bias, dismissed diagnoses, and the vulvar vestibule
3
Menopause proteomic scores associated with cognitive aging, dementia risk
4
FDA approves IDE for pivotal study of Evident ovarian cancer screening test
5